from Wiktionary, Creative Commons Attribution/Share-Alike License

  • n. A monoclonal antibody being developed as a drug to slow tumour growth.


from Wiktionary, Creative Commons Attribution/Share-Alike License

-tu- +‎ -zu- +‎ -mab


  • In a large international study, an experimental drug from Genentech called pertuzumab held cancer at bay for a median of 18 months when given with standard treatment, versus 12 months for others given only the usual treatment.

    Yahoo! News: Business - Opinion

  • They were given either a new drug called pertuzumab, combined with standard therapy, or standard therapy alone. Top Stories

  • New clinical data showed an experimental drug called pertuzumab prolonged the survival time for wome ...


  • Roche said the results of the phase III study showed how pertuzumab, a drug that works by inhibiting growth of cancer-causing protein HER2, together with its cancer drug Herceptin and chemotherapy, helped women who suffer from this specific breast cancer.

    Roche to File Cancer Drug

  • But others welcomed the move as pertuzumab could help the Swiss pharmaceutical giant safeguard its breast cancer franchise in the U.S.

    Roche to File Cancer Drug

  • ZURICH— Roche Holding AG Friday said it will file cancer drug pertuzumab for approval in Europe and the U.S. later this year.

    Roche to File Cancer Drug

  • But Mr. Schwan said that recent drug trial data, including cancer treatments Zelboraf, vismodegib and pertuzumab, bode well for Roche's future, which, unlike many of its competitors, isn't under the immediate threat of patent losses.

    Roche's Profit Drops 6%, But Lifts Outlook

  • Investors are keenly awaiting new data on a number of promising medicines, such as breast cancer drug pertuzumab, which Roche is aiming to submit for approval by the end of this year.

    Strong Swiss franc hits Roche sales

  • Roche plans to file pertuzumab in Europe and in the U.S. later this year and is in the process of entering late stage trials for Metmab and lebrikizumab.

    A Healthy Forecast for Pharma

  • Among Roche's most promising experimental compounds, Mr. Schwan says, are lung-cancer treatment Metmab, asthma compound lebrikizumab and breast-cancer treatment pertuzumab.

    A Healthy Forecast for Pharma


Log in or sign up to get involved in the conversation. It's quick and easy.